Cabaletta Bio Clinical Trial Pipeline: 5 Active Trials, 3 Changes This Month

5

Active Trials

5

Recruiting

1

Phase 3

3

Disease Areas

3

Changes, 30 Days

What Changed in the Last 30 Days

Detected	Trial	Change
2026-08-14	NCT06359041 RESET-MG: A Study to Evaluate the Safety and Efficacy of CABA-201 in Participants With…	Enrollment reopened
2026-08-14	NCT06359041 RESET-MG: A Study to Evaluate the Safety and Efficacy of CABA-201 in Participants With…	Enrollment increased: 12 -> 24 participants
2026-08-14	NCT06359041 RESET-MG: A Study to Evaluate the Safety and Efficacy of CABA-201 in Participants With…	Trial arms changed: 1 -> 2

Active Trials by Phase

Phase 2/3

1

Phase 1/2

4

Active Trials

NCT ID	Title	Condition	Status
Phase 2/3
NCT06154252	RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in…	Idiopathic Inflammatory Myopathy	Recruiting
Phase 1/2
NCT06121297	RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201…	Systemic Lupus Erythematosus	Recruiting
NCT04422912	A Phase 1/2, Open-label, Safety and Dosing Study of Autologous CART Cells (Desmoglein 3…	Pemphigus Vulgaris	Recruiting
NCT06328777	RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a…	Systemic Sclerosis	Recruiting
NCT06359041	RESET-MG: A Study to Evaluate the Safety and Efficacy of CABA-201 in Participants With…	Generalized Myasthenia Gravis (gMG)	Recruiting

Disease Areas

Get alerts when Cabaletta Bio's trials change

Status changes, date slips, and new filings — detected daily, delivered to your inbox.